FIBROGEN INC Quarterly Entity Common Stock, Shares Outstanding from Q1 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Fibrogen Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2015 to Q3 2024.
  • Fibrogen Inc Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 101M shares, a 2.47% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 101M +2.43M +2.47% Oct 31, 2024 10-Q 2024-11-12
Q2 2024 100M +2.19M +2.23% Jul 31, 2024 10-Q 2024-08-06
Q1 2024 99.5M +1.89M +1.94% Apr 30, 2024 10-Q 2024-05-06
Q4 2023 98.8M +4.59M +4.87% Jan 31, 2024 10-K 2024-02-26
Q3 2023 98.3M +4.38M +4.66% Oct 31, 2023 10-Q 2023-11-06
Q2 2023 98.2M +4.47M +4.77% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 97.6M +4.28M +4.59% Apr 30, 2023 10-Q 2023-05-08
Q4 2022 94.2M +1.18M +1.27% Jan 31, 2023 10-K 2023-02-27
Q3 2022 94M +1.25M +1.35% Oct 31, 2022 10-Q 2022-11-07
Q2 2022 93.7M +1.12M +1.21% Jul 31, 2022 10-Q 2022-08-08
Q1 2022 93.3M +1.17M +1.27% Apr 30, 2022 10-Q 2022-05-09
Q4 2021 93M +1.44M +1.57% Jan 31, 2022 10-K/A 2022-03-04
Q3 2021 92.7M +1.7M +1.87% Oct 31, 2021 10-Q 2021-11-09
Q2 2021 92.6M +2.27M +2.51% Jul 31, 2021 10-Q 2021-08-09
Q1 2021 92.1M +3.02M +3.39% Apr 30, 2021 10-Q 2021-05-10
Q4 2020 91.6M +3.56M +4.05% Jan 31, 2021 10-K 2021-03-01
Q3 2020 91M +3.76M +4.31% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 90.4M +3.44M +3.96% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 89.1M +2.88M +3.34% Apr 30, 2020 10-Q 2020-05-07
Q4 2019 88M +2.44M +2.85% Jan 31, 2020 10-K 2020-03-02
Q3 2019 87.3M +2.27M +2.67% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 86.9M +2.58M +3.06% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 86.2M +2.7M +3.23% Apr 30, 2019 10-Q 2019-05-09
Q4 2018 85.6M +2.9M +3.5% Jan 31, 2019 10-K 2019-02-27
Q3 2018 85M +2.97M +3.62% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 84.3M +13.1M +18.5% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 83.5M +13.6M +19.4% Apr 30, 2018 10-Q 2018-05-09
Q4 2017 82.7M +18.8M +29.4% Jan 31, 2018 10-K 2018-02-27
Q3 2017 82M +18.8M +29.8% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 71.2M +8.41M +13.4% Jul 31, 2017 10-Q 2017-08-07
Q1 2017 69.9M +7.49M +12% Apr 28, 2017 10-Q 2017-05-09
Q4 2016 63.9M +1.81M +2.92% Jan 31, 2017 10-K 2017-03-01
Q3 2016 63.2M +1.82M +2.98% Oct 31, 2016 10-Q 2016-11-08
Q2 2016 62.8M +2.22M +3.67% Jul 31, 2016 10-Q 2016-08-08
Q1 2016 62.5M +3.18M +5.37% Apr 30, 2016 10-Q 2016-05-09
Q4 2015 62.1M Jan 31, 2016 10-K 2016-02-29
Q3 2015 61.3M Oct 31, 2015 10-Q 2015-11-12
Q2 2015 60.6M Jul 31, 2015 10-Q 2015-08-13
Q1 2015 59.3M Apr 30, 2015 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.